Assessment of MDD management in Andalusia - PismaEP

Study identifier:NIS-NES-XXX-2011/3

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Assessment of MDD management strategies in Andalusia: A Sub-analysis of the PismaEP Study

Medical condition

MDD management strategies

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

5309

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Jun 2012

Primary Completion Date: 01 Sept 2013

Study Completion Date: 01 Sept 2013

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Aug 2014 by AstraZeneca

Collaborators

Inclusion and exclusion criteria

Location

Research Site

Granada, Spain

Arms	Assigned Interventions
1	-

"There is no result for the study"

Documents available

NIS-NES-XXX-2011-3 Clinical Study Report Synopsis
Download
Trial Results Summaries
Available here

Contacts

Investigators

Principal Investigator

Jorge Cervilla

Hospital San Cecilio